Novel immune‐related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Novel immune‐related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma

Published:2022-04-20 Issue:6 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Zhou Libin¹²^ORCID,Fang Hualong³,Yin Min²,Long Huimin²,Weng Guobin⁴⁵

Affiliation:

1. Department of Urology The Affiliated Lihuili Hospital Ningbo University Ningbo China

2. Department of Urology Ningbo Medical Centre Lihuili Hospital Ningbo China

3. The First Affiliated Hospital of Nanchang Nanchang China

4. Department of Urology The Affiliated Yinzhou No 2 Hospital, Ningbo University Ningbo China

5. Department of Urology Ningbo Yinzhou No 2 Hospital Ningbo China

Funder

Natural Science Foundation of Ningbo

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24409

Reference58 articles.

1. The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

2. Treatment of renal cell carcinoma: Current status and future directions

3. Checkpoint inhibitor immunotherapy in kidney cancer

4. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

5. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell transcriptomic construction of fibroblast score for analysis of immune infiltration in primary and metastatic ovarian cancer;2024-06-12

2. Low ACADM expression predicts poor prognosis and suppressive tumor microenvironment in clear cell renal cell carcinoma;Scientific Reports;2024-04-25